Reimbursement Is Getting Better Insurance coverage for GLP-1 weight-loss medications is expanding rapidly : Many commercial insurers now cover Wegovy, Saxenda, and Mounjaro with prior authorization (typically requiring BMI 30 or 27 with comorbidity) Medicare will begin covering anti-obesity medications in 2026 a game-changer for providers seeing older patients State Medicaid programs are adding coverage (varies by state, but momentum is strong) For the clinical visit itself : Bill standard E/M codes (99213-99215 for follow-ups, 99202-99205 for new patients) Psychiatrists get 100% of Medicare physician fee schedule (~$75-150 per visit depending on complexity) PMHNPs typically get 85% of physician rates for Medicare (though some state Medicaid programs like Illinois pay NPs at 100%) Telehealth parity laws in CA, NY, IL, and many other states ensure equal reimbursement for video visits Typical visit economics : 15-20 minute medication management follow-up: $100-150 reimbursement Initial evaluation (45 min): $200-250 If you see 4 weight management patients per day (1 hour total), thats $400-600 in revenue Compare that to traditional psychiatric med management (already your bread and butter) its the same billing model, just applied to a different clinical problem
A proposed intestinal mechanism for the effect of riboflavin deficiency on iron loss in the rat
Culprit #1: The Quality of Your Peptide This is the critical, non-negotiable element
Published trials are sparse, but a 2023 observational study reported modest additional weight loss (35 lbs over 12 weeks) with combination therapy versus single-agent, though nausea and dizziness occurred in 34% of patients
